Industry News Sponsored by
Symrise AG has acquired 11.8% of the capital and 12.1% of the voting rights in Swedish probiotic company Probi, making it the largest shareholder in the company.
Symrise has acquired a total of 1,102,301 shares in Probi, which is a Lund, Sweden-based publicly traded company which has customers in the functional foods and consumer health care business areas.
“Symrise has significant industrial expertise and a global network," said Michael Oredsson, Probi's CEO. "There is currently no industrial collaboration between Probi and Symrise, but we intend to investigate the benefits of such a partnership."